Business Description
Founded in 1997 and based in South Korea, SunBioInc. uses pegylation technology to develop and sell a range of healthcare products worldwide. Its current offerings include biosimilar treatments, medical devices for dry mouth and arthritic knees, and specialty chemical ingredients. The company also has several promising treatments in early-stage development targeting brain stroke and chronic anemia.
